Alimta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma
Condition:   Pleural Mesothelioma Intervention:   Drug: Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials

A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Condition:   MPM Interventions:   Drug: PM8002;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Carboplatin Sponsor:   Biotheus Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials